| 3 Marijuana Stocks For The Long Term Investing |
Marijuana stocks hold lots of potential for home-run investments in the future. In 2018, most pot stocks saw their first wave of the green rush. Yet over the last several years, this has not been the case and things have changed drastically. Still, the way companies are keeping up with. Market demand profits and revenue are steadily rising. However, this success has played very little in how most marijuana stocks trade. |
marijuanastocks.com |
2025-05-02 14:07:05 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Announces the Completion of a Multimillion Dollar Investment and Renaming of B.C. Manufacturing Facility |
NASDAQ | TSX: ACB Company's Long-Standing Investment in Operational Excellence Continues with Industry Leading Upgrades and Renaming the Facility to Aurora Alpine EDMONTON, AB , April 30, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the completion of a multi-year investment of $3 million in improvements to its manufacturing facility in Pemberton, British Columbia. These upgrades are a combination of Aurora's proprietary high-performing genetics and state-of-the-art engineering design which have resulted in optimal cultivation conditions, expanded output, and superior product quality. |
prnewswire.com |
2025-04-30 11:00:00 |
Czytaj oryginał (ang.) |
| 3 Canadian Marijuana Stocks That Could See Big Future Gains |
When it comes to finding marijuana stocks to buy a happy medium or silver lining at this time is tough to do. Not becuase the low share prices from some of the top-performing companies dont look appetizing. It is more due to the consistent falls in the sector no real upward push. Even as the cannabis industry as a whole is thriving and showing great long-term success. |
marijuanastocks.com |
2025-04-16 14:25:20 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Introduces the Company's First Inhalable Resin Cartridges for Patients in the United Kingdom |
NASDAQ | TSX: ACB Canada's Leading Medical Cannabis Company Expands Patient Offering with Innovative Dosage Solution EDMONTON, AB , April 15, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced today the availability of medical cannabis concentrates to patients in the United Kingdom (UK). This launch marks the company's meaningful step in offering its proprietary cultivar-specific inhalable cannabis extracts in the UK market. |
prnewswire.com |
2025-04-15 11:00:00 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Recognized for Executive Gender Diversity by The Globe and Mail |
Canada's Largest Medical Cannabis Company is an Honouree in The Globe and Mail's 2025 Report on Business Magazine's sixth annual Women Lead Here List EDMONTON, AB , March 31, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has been named an honouree on the Globe & Mail's 2025 Report on Business, Women Lead Here list. This annual editorial benchmark recognizes the top publicly traded Canadian companies with the highest gender diversity at the executive level. |
prnewswire.com |
2025-03-31 11:00:00 |
Czytaj oryginał (ang.) |
| Top Canadian Cannabis Stocks to Watch in April 2025 |
Top Canadian cannabis stocks are attracting attention this week as investors seek opportunities in a rapidly evolving industry. Companies like Cronos Group, SNDL Inc., and Aurora Cannabis continue strengthening their positions in Canadian and international markets. Though based in Canada, these firms have exposure to the U.S. through strategic investments and partnerships. The U.S. cannabis industry is expected to generate over $45 billion annually by 2025. Legalization efforts are expanding, and several states are reviewing new adult-use and medical cannabis bills. At the same time, court rulings and state-level decisions continue to shape the legal landscape. Because of this, Canadian companies with U.S. exposure are drawing increased interest from traders and long-term investors alike. |
marijuanastocks.com |
2025-03-30 14:00:34 |
Czytaj oryginał (ang.) |
| Ethos Cannabis Expands Pennsylvania Presence with Aurora Launch and Title Sponsorship at the Pennsylvania Cannabis Convention |
MSO Unveils Premium Infused Live Resin Flower and Leads Industry Conversations at Pennsylvania Cannabis Convention MSO Unveils Premium Infused Live Resin Flower and Leads Industry Conversations at Pennsylvania Cannabis Convention |
globenewswire.com |
2025-03-28 10:30:00 |
Czytaj oryginał (ang.) |
| Aurora Cannabis to Speak at the Global Cannabis Regulatory Summit |
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company to Participate as an Industry Leader in the Inaugural Regulatory Event in Washington, D.C. EDMONTON, AB , March 25, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to be attending, sponsoring and speaking at the 2025 Global Cannabis Regulatory Summit (GCRS), held within the U.S. Capitol Complex in Washington, D.C. |
prnewswire.com |
2025-03-25 19:01:00 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars |
NASDAQ | TSX: ACB Groundbreaking research at Aurora Coast, Aurora's world-class research and development facility, sets new standard in cannabis science EDMONTON, AB , March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides strong protection against this pathogen in cannabis sativa. The development of this proprietary genetic marker technology, which is now in use in Aurora's breeding program, is set to produce powdery mildew resistant cultivars that will be explored for commercial launch this year. |
prnewswire.com |
2025-03-20 09:00:00 |
Czytaj oryginał (ang.) |
| 3 Canadian Marijuana Stocks To Watch For Future Gains 2025 |
Marijuana stocks have been facing a downward trend in the market for some time. A big reason is regulatory uncertainty and reform issues. Legislative changes, particularly in major markets like the U.S., can greatly affect how shareholders think. Additionally, oversupply in certain regions has led to falling prices, which negatively affects revenue for companies in the sector. This has created a volatile sector where the trading behavior of the most public companies is more on the low end. |
marijuanastocks.com |
2025-03-19 11:01:49 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Rides the Global Legalization Wave: Should You Invest? |
ACB capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, advanced genetics and deep regulatory knowledge. |
zacks.com |
2025-03-18 16:10:20 |
Czytaj oryginał (ang.) |
| Are Medical Stocks Lagging Aurora Cannabis (ACB) This Year? |
Here is how Aurora Cannabis Inc. (ACB) and Concentra Group (CON) have performed compared to their sector so far this year. |
zacks.com |
2025-03-17 12:40:29 |
Czytaj oryginał (ang.) |
| High-Potential Canadian Cannabis Stocks to Watch This Month |
The Canadian cannabis sector remains a key player in the global market. Many top Canadian companies are expanding into the U.S. in anticipation of future federal legalization. The U.S. cannabis industry continues to grow rapidly, with sales expected to surpass $40 billion in 2025. More states are legalizing cannabis, increasing market opportunities for Canadian producers. Recently, lawmakers introduced new federal reform bills that could ease banking restrictions and boost industry expansion. Investors are closely watching these developments as they could impact stock performance. With growing demand and regulatory progress, top Canadian cannabis stocks remain attractive. |
marijuanastocks.com |
2025-03-13 12:00:23 |
Czytaj oryginał (ang.) |
| Investing in Cannabis: Best Canadian Stocks to Watch in March 2025 |
The Canadian cannabis sector continues to evolve as companies expand operations and navigate industry challenges. Many Canadian cannabis producers are looking beyond their domestic market and establishing strong positions in the U.S. Despite federal restrictions. Some have developed partnerships, investments, or business strategies that position them well for eventual legalization. |
marijuanastocks.com |
2025-03-08 17:00:53 |
Czytaj oryginał (ang.) |
| Top Marijuana Stocks To Know In Today's Stock Market 2025 |
As the cannabis industry continues to grow, more companies are expanding their product lines beyond traditional flower sales. This includes edibles, oils, and wellness products, attracting a broader consumer base. The demand for more cannabis products is helping bridge some gaps between existing players. For example, when companies partner in some way to create and release products, it often has a positive impact all the way around for the companies. |
marijuanastocks.com |
2025-03-05 11:38:33 |
Czytaj oryginał (ang.) |
| Is Aurora Cannabis (ACB) Stock Outpacing Its Medical Peers This Year? |
Here is how Aurora Cannabis Inc. (ACB) and AdaptHealth Corp. (AHCO) have performed compared to their sector so far this year. |
zacks.com |
2025-02-26 12:45:56 |
Czytaj oryginał (ang.) |
| Wall Street Analysts Predict a 25.67% Upside in Aurora Cannabis (ACB): Here's What You Should Know |
The mean of analysts' price targets for Aurora Cannabis (ACB) points to a 25.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. |
zacks.com |
2025-02-25 13:00:45 |
Czytaj oryginał (ang.) |
| Aurora Cannabis: This Phoenix Has Risen From The Ashes (Strong Buy Initiation) |
Aurora Cannabis has transformed its margins, market position, and balance sheet over the last few years, and the stock is now highly 'investible'. ACB's strategic focus on the global medical cannabis market has led to gross margin growth and reduced competition, enhancing top and bottom-line results. The stock is trading at an extremely attractive multiple, and we see significant upside if ACB continues to execute and market awareness of the story improves. |
seekingalpha.com |
2025-02-22 08:44:55 |
Czytaj oryginał (ang.) |
| Best Momentum Stocks to Buy for February 21st |
ACB, BHRB and BJ made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 21, 2024. |
zacks.com |
2025-02-21 13:15:33 |
Czytaj oryginał (ang.) |
| New Strong Buy Stocks for February 21st |
BHRB, ACB, MWA, BJ and PRTH have been added to the Zacks Rank #1 (Strong Buy) List on February 21, 2024. |
zacks.com |
2025-02-21 08:40:25 |
Czytaj oryginał (ang.) |
| Best Value Stocks to Buy for February 21st |
ACB, and PRTH made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 21, 2024. |
zacks.com |
2025-02-21 06:00:20 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Expands Medical Cannabis Pastille Offerings in Australia |
Canada's Leading Medical Cannabis Company Broadens Innovative Product Portfolio to Growing Market in Australia EDMONTON, AB , Feb. 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced today the company's extended pastille offerings in Australia. This expansion marks another meaningful step in Aurora's deep commitment to offering patients a diverse range of high-quality, premium medical cannabis products to meet their various needs and interests. |
prnewswire.com |
2025-02-20 19:30:00 |
Czytaj oryginał (ang.) |
| Breaking Down Barriers: Aurora Cannabis Eases Patient Access to High Quality Medical Cannabis Products in Australia |
NASDAQ | TSX: ACB Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession Card Requirements to Access IndiMed Products in Australia EDMONTON, AB , Feb. 14, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the concession card requirement for patients to access medical cannabis products under the Company's IndiMed brand. By removing this eligibility barrier, any patient in Australia can now be prescribed IndiMed products, providing greater patient access to high quality medical cannabis options. |
prnewswire.com |
2025-02-14 20:10:00 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Skyrockets After Earnings: Should You Buy Into the Rally? |
The year is a more than a month old, but Aurora Cannabis (ACB -2.87%) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year began -- and that rally began only a few days ago. |
fool.com |
2025-02-12 07:15:00 |
Czytaj oryginał (ang.) |
| All You Need to Know About Aurora Cannabis (ACB) Rating Upgrade to Strong Buy |
Aurora Cannabis (ACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). |
zacks.com |
2025-02-10 15:01:25 |
Czytaj oryginał (ang.) |
| Aurora Cannabis: Strong Buy On Blowout Results And Constructive Outlook |
Last week, Aurora Cannabis reported blowout Q3/FY2025 results with sales, gross margins, profitability, and free cash flow reaching new all-time highs. As a leader in the medical cannabis space, the company is enjoying premium margins. Following the descheduling of cannabis in Germany last year, sales in Europe have increased substantially. Cash, restricted cash and cash equivalents increased to $180.2 million. The company's core cannabis operations remain debt free. |
seekingalpha.com |
2025-02-09 22:04:28 |
Czytaj oryginał (ang.) |
| 3 Marijuana Stocks To Watch As Trading Momentum May Soon Rise |
The patience of some marijuana stock investors is still being tested. The public sector for cannabis is a victim of uncertainty and fear in more grey areas. What this means is in the USA there is no federal reform that protects legal operators in any way. Yet states have independently voted to legalize cannabis. From this legal markets are created and legal companies can now produce a federally illegal product. |
marijuanastocks.com |
2025-02-07 13:24:05 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Announces Supply Agreement with SNDL |
NASDAQ | TSX: ACB Agreement Complements Existing Relationship Focused on the Supply of Premium Cannabis EDMONTON, AB , February 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to announce a strategic supply agreement (the "Agreement") with SNDL Inc. ("SNDL"), a Canadian licensed producer and vertically integrated cannabis enterprise. Under this Agreement, SNDL is expected to supply Aurora with premium cannabis flower product grown at SNDL's indoor facility in Atholville, New Brunswick. |
prnewswire.com |
2025-02-06 22:50:00 |
Czytaj oryginał (ang.) |
| Aurora Cannabis: Remarkable Recovery |
Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins and generating solid cash flows. The company reported FQ3 revenues of C$88 million and a significant improvement in adjusted EBITDA to C$23 million, with free cash flow of C$27 million. ACB stock is trading at just 1x forward sales, presenting a buying opportunity, especially on dips, as the company continues to show financial improvement. |
seekingalpha.com |
2025-02-06 10:15:00 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Inc. (ACB) Q3 2025 Earnings Call Transcript |
Aurora Cannabis Inc. (NASDAQ:ACB ) Q3 2025 Earnings Conference Call February 5, 2025 8:00 AM ET Company Participants Kevin Niland - Director of Strategic Finance and Investor Relations Miguel Martin - Chief Executive Officer and Executive Chairman Simona King - Chief Financial Officer Conference Call Participants William Kirk - ROTH Capital Partners Frederico Gomes - ATB Capital Markets Derek Lessard - TD Cowen Matt Bottomley - Canaccord Genuity Douglas Miehm - RBC Capital Markets Operator Greetings and welcome to the Aurora Cannabis Inc. Third Quarter 2025 Results Conference Call. All participants will be in a listen-only mode and a question-and-answer session will follow the formal presentation. |
seekingalpha.com |
2025-02-05 14:23:55 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Inc. (ACB) Surpasses Q3 Earnings and Revenue Estimates |
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to loss of $0.20 per share a year ago. |
zacks.com |
2025-02-05 11:51:44 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Stock Jumps On 'Record-Breaking' Q3 Earnings |
Canada-based global medical cannabis company Aurora Cannabis Inc ACB reported a third-quarter fiscal 2025 net revenue of CA$88.2 million, compared to CA$64.4 million a year ago. |
benzinga.com |
2025-02-05 11:35:26 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Announces Fiscal 2025 Third Quarter Results |
NASDAQ | TSX: ACB Reports Total Net Revenue1 of $88.2 Million, up 37% YoY, Including Record Net Revenue1 of $68.1 Million in Global Medical Cannabis, up 51% YoY Generates Record Net Income of $31.2 Million, up 282% YoY, and Record Adjusted EBITDA1 of $23.1 Million, up 316% YoY Achieves Target of Positive Free Cash Flow1 in Q3, Generating $27.4 Million of Free Cash Flow1 Maintains Strong Balance Sheet with $180 Million of Cash and Debt-Free Cannabis Business2 EDMONTON, AB , Feb. 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter fiscal 2025. "This quarter was record-breaking for Aurora, driven by all-time highs in global medical net revenue1, net income, adjusted EBITDA1, and free cash flow1. |
prnewswire.com |
2025-02-05 09:00:00 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Launches First Domestically Grown Medical Cannabis Brand in Germany Under New Cultivation License |
NASDAQ | TSX: ACB Investment in the region continues with the launch of IndiMed, the company's first locally grown brand in Germany EDMONTON, AB , Jan. 23, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company's first German-cultivated medical cannabis product, under the brand IndiMed. Manufactured at Aurora's leading EU-GMP facility in Leuna, Germany, the new brand offers a supply of high-quality, locally grown and sold, medical cannabis for the country's expanding patient base. |
prnewswire.com |
2025-01-23 09:00:00 |
Czytaj oryginał (ang.) |
| Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call |
NASDAQ | TSX: ACB EDMONTON, AB , Jan. 22, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2025 on Wednesday, February 5, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. |
prnewswire.com |
2025-01-22 19:02:00 |
Czytaj oryginał (ang.) |
| 2025 Outlook: The Best Canadian Cannabis Stocks to Watch Now |
The cannabis industry continues to evolve rapidly, presenting unique investment opportunities, especially in Canadian cannabis stocks. With the U.S. cannabis market projected to exceed $40 billion by 2025, legalization efforts are gaining traction. Recent news highlights growing bipartisan support for federal cannabis reform in the U.S., which could further boost industry expansion. Canadian cannabis companies, with their well-established infrastructure and international presence, are strategically positioned to capitalize on this growth. Tracking key stocks with solid fundamentals and technical setups becomes essential as investors look for potential gains. |
marijuanastocks.com |
2024-12-26 12:00:18 |
Czytaj oryginał (ang.) |
| Better Marijuana Stock: Aurora Cannabis or Tilray Brands? |
The global cannabis market tells a tale of survival and adaptation. After a brutal multiyear shakeout that saw dozens of companies fold or merge, the remaining players have emerged battle-tested and strategically transformed. |
fool.com |
2024-12-19 09:15:00 |
Czytaj oryginał (ang.) |
| Aurora Announces Distribution Partnership Between MedReleaf Australia and The Entourage Effect |
NASDAQ | TSX: ACB The collaboration aims to broaden access of premium medical cannabis products to Australian patients EDMONTON, AB , Dec. 17, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce a distribution partnership between The Entourage Effect and MedReleaf Australia. The Entourage Effect provides comprehensive distribution and support services to pharmacies in Australia and will serve as a wholesaler for MedReleaf Australia's leading portfolio of products under the CraftPlant, Aurora, and IndiMed brands, furthering the mission to expand access for Australian patients. |
prnewswire.com |
2024-12-17 09:00:00 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities |
Cannabis stocks have faced significant challenges recently, driven by political uncertainty that has further weighed on a sector still struggling to regain its footing since the overhyped all-time highs of 2021. |
benzinga.com |
2024-11-26 14:37:15 |
Czytaj oryginał (ang.) |
| Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility |
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company Continues to Offer Greater Choice for Patients EDMONTON, AB , Nov. 26, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces developments in cannabis science from Aurora's world class research and genetics facility, Aurora Coast. With a continued focus on premium, science-driven insights, these latest innovations demonstrate Aurora's commitment to providing patients with ongoing access to superior product offerings on AuroraMedical.com. |
prnewswire.com |
2024-11-26 09:00:00 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Expands Innovative Recreational Product Portfolio |
NASDAQ | TSX: ACB Introduces New Products and Flavours across Greybeard, San Rafael '71 and Tasty's brands EDMONTON, AB , Nov. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is excited to announce its latest lineup of innovations from Greybeard, San Rafael '71 and Tasty's brands. With a continued focus on premium, science-driven offerings, this expanded lineup represents Aurora's commitment to delivering exceptional high quality, cutting-edge and diverse options for Canadian cannabis consumers. |
prnewswire.com |
2024-11-20 09:30:00 |
Czytaj oryginał (ang.) |
| Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy + |
The 'Undercovered' Dozen series highlights 12 lesser-covered stocks from the past week, aiming to spark ideas and discussions among retail investors. Veradigm Inc. is undervalued due to regulatory pressures, but has significant upside potential with strategic buyers potentially paying mid- or high-teens per share. Casey's General Stores has outperformed its peers and the S&P 500 due to its strategic positioning in rural areas and strong operational execution. |
seekingalpha.com |
2024-11-16 10:00:00 |
Czytaj oryginał (ang.) |
| 3 Marijuana Stocks For Today Watchlist |
The future of cannabis investing rests in the hands of politicians who may not have the industry's best interests at heart. Right now, the majority of marijuana stocks are feeling the impact of cannabis politics surrounding reform and regulatory issues. Each party, Republicans and Democrats, walks a different path to passing comprehensive reform and looking at the sector as a whole. |
marijuanastocks.com |
2024-11-15 11:44:18 |
Czytaj oryginał (ang.) |
| Aurora Cannabis: Buy The Election Overreaction |
Aurora Cannabis dropped over 10%, along with the broader cannabis market, due to concerns over U.S. election results. Despite this, Aurora has no U.S. cannabis operations and is unaffected. Aurora reported robust revenue growth, with a 29% YoY increase, driven by a 93% rise in international medical cannabis sales. The company re-affirmed positive free cash flow expectations for Q3 and demonstrated strong spending discipline, maintaining positive adjusted EBITDA for the 8th consecutive quarter. |
seekingalpha.com |
2024-11-11 14:41:22 |
Czytaj oryginał (ang.) |
| Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization |
Amendment 3 – which would have legalized the recreational use of marijuana in the state's constitution – failed to receive the 60% support needed to pass under Florida law. |
nypost.com |
2024-11-07 14:14:17 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Inc. (ACB) Beats Q2 Earnings and Revenue Estimates |
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.22 per share. This compares to loss of $0.50 per share a year ago. |
zacks.com |
2024-11-06 11:46:13 |
Czytaj oryginał (ang.) |
| Cannabis stocks tank as Florida votes against recreational marijuana |
Shares in cannabis stocks such as Trulieve Cannabis Corp. (CSE:TRUL), Curaleaf Hldgs Inc. (CSE:CURA, OTCQX:CURLF) and Verano Holdings Corp (CSE:VRNO, OTCQX:VRNOF) tanked after Florida rejected legalization of recreational marijuana. A ballot measure, known as Amendment 3, which would have allowed adults to possess up to three ounces of marijuana, failed to obtain the required 60% of support from voters yesterday. |
proactiveinvestors.com |
2024-11-06 11:42:30 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Inc. (ACB) Q2 2025 Earnings Call Transcript |
Aurora Cannabis Inc. (NASDAQ:ACB ) Q2 2025 Earnings Conference Call November 6, 2024 8:00 AM ET Company Participants Kevin Niland - Director, Strategic Finance and IR Miguel Martin - CEO Simona King - CFO Conference Call Participants Frederico Gomes - ATB Capital Markets Pablo Zuanic - Zuanic & Associates Operator Greetings and welcome to the Aurora Cannabis Inc. Second Quarter 2025 Results Conference Call. all participants will be in a listen-only mode and a question-and-answer session will follow the formal presentation. |
seekingalpha.com |
2024-11-06 11:37:31 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Announces Fiscal 2025 Second Quarter Results |
NASDAQ | TSX: ACB Record Adjusted EBITDA1 of $10.1 Million, a YoY increase of 210% Quarterly Net Revenue1 up 29% YoY to $81.1 Million, with 41% growth in Global Medical Cannabis Re-Affirms Target of Positive Free Cash Flow1 in the Quarter Ending December 31, 2024 Maintains Strong Balance Sheet with ~$152 Million of Cash and a Debt-Free Cannabis Business2 EDMONTON, AB , Nov. 6, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter fiscal 2025. "Our strong quarterly results demonstrate Aurora's leadership in global medical cannabis and ability to capitalize on opportunities within rapidly growing markets such as Australia, Germany, Poland, and the UK. |
prnewswire.com |
2024-11-06 09:00:00 |
Czytaj oryginał (ang.) |
| Aurora Cannabis to Host Second Quarter 2025 Investor Conference Call |
NASDAQ | TSX: ACB EDMONTON, AB , Oct. 24, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today announced today that it has scheduled a conference call to discuss the results for its second quarter 2025 on Wednesday, November 6, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. |
prnewswire.com |
2024-10-24 21:45:00 |
Czytaj oryginał (ang.) |
| Aurora Cannabis Stock Rises Following Medical Cannabis Oil Launch |
ACB and MedReleaf Australia launch premium medical cannabis oils, offering tailored cannabinoid formulations for patient care. |
zacks.com |
2024-10-17 17:01:30 |
Czytaj oryginał (ang.) |
| Aurora Introduces Innovative Cannabis Oil Range to Meet Diverse Patient Needs in Australia |
NASDAQ | TSX: ACB Canada's Leading Medical Cannabis Company and MedReleaf Australia Launch New Oil Products for Enhanced Patient Care Options EDMONTON, AB , Oct. 16, 2024 /CNW/ - Aurora Cannabis Inc., (NASDAQ: ACB) (TSX: ACB) – the Canadian based global leader in medical cannabis, in conjunction with MedReleaf Australia, is pleased to announce an enhanced product range of premium medical cannabis oil in Australia. This expansion reinforces Aurora's dedication to providing high-quality, innovative cannabis solutions to patients around the world. |
prnewswire.com |
2024-10-16 11:00:00 |
Czytaj oryginał (ang.) |
| Is It Time to Load Up on Aurora Cannabis Stock? |
This Canadian pot stock has defied the broader downturn among its peer group in 2024. |
fool.com |
2024-10-09 11:45:00 |
Czytaj oryginał (ang.) |
| Profit from the Green Wave: Top Cannabis Stocks to Watch |
The cannabis sector has captivated investors, promising a green rush of potential profits. However, the path to profitability has been rocky, marked by regulatory hurdles, intense competition, and, at times, a volatile market. |
benzinga.com |
2024-10-03 15:29:41 |
Czytaj oryginał (ang.) |
| ACB Stock Likely to Gain From Genome BC-Funded Aroma Research Project |
Aurora Cannabis' new collaboration on the Genome BC-Funded Project addresses distinct cannabis aromas. |
zacks.com |
2024-10-03 14:50:59 |
Czytaj oryginał (ang.) |